An inclusive team of scientists at Tessenderlo Group, headquartered in Belgium, has announced a recent breakthrough in bioprinting with the creation of new gelatin materials for tissue engineering. Today, they announce the release of their first bio-ink to take its place in the Claro™ series of tissue-engineering products.
- Much greater affordability for companies engaged in bioprinting
- Proven printing time of up to two hours
- Eliminates issues with clogging
- Maintains positive qualities of gelatin during printing, and is highly biocompatible
- No printability enhancers
“The propriety Claro technology enables printing with lower pressure and excellent shape fidelity, without affecting the biocompatibility and final gel strength of the construct. This makes it the perfect material for 3D printing tissue engineering applications,” states the Tessenderlo Group in their most recent press release.
With headquarters around the globe, Tessenderlo Group employs around 4,600 people, with revenues of $1.6 billion last year. Tessenderlo is a leading industrial company known for their emphasis on progressive agricultural processes and solutions:
“Tessenderlo Group continually strives to find more sustainable solutions. We thereby aim to minimize our ecological footprint and to maximize the contribution of our products in the evolution towards achieving a green economy. We offer various products and environmentally friendly solutions, in which we typically reclaim and transform by-products from other industries,” states Tessenderlo on their website.
“Whether it is in the products and solutions we supply or the way in which we produce them, the care we show towards our planet and its resources is at the very heart of all our businesses. This is because we believe that every molecule counts.”
Meet with Tessenderlo Group scientists to find out more about Claro when they are exhibiting at the Biofabrication & Biomanufacturing Europe 2019 event in Rotterdam, The Netherlands, from June 20-21. Contact the company at firstname.lastname@example.org if you would like to set up an appointment to meet with their team. Are you interested in ordering a sample of ClaroBGI600? Find out more here.
There is so much to get excited about in the world of 3D printing as we learn about innovations rocking industry and changing the world. And while much of the thriving 3D printing marketplace revolves around countless choices in shiny new hardware, the realm of materials is vast too—whether you are a user exploring polymers like ABS or PLA, an industrialist branching out with materials like concrete or metal, or a scientist customizing your own tools and composite materials in the lab. Bioprinting has taken off though, evidenced by the massive progress in tissue engineering and the ongoing supply of new bioinks allowing researchers to fabricate implants and more with cell-laden materials.
What do you think of this news? Let us know your thoughts! Join the discussion of this and other 3D printing topics at 3DPrintBoard.com.[Source / Images: Tessenderlo Group]
You May Also Like
3D Printing Awakens Renewed Interest in Polymeric Heart Valves for Patient-Specific Treatment
Authors Charles D. Resor and Deepak L Batte review the recent work of André R. Studart and his co-researchers in creating artificial heart valves via 3D printing. Their findings are...
3D Printing News Briefs: July 19, 2019
We’ve got a new partnership to tell you about in today’s 3D Printing News Briefs, followed by a software update and some news about 3D printing in the hospital. FIT...
Fortify Closes $10M Series A Funding Led by Accel
Fortify, known for their next-generation composites and Digital Composite Technology (DCM), has just completed a $10M Series A funding led by Accel. The Boston-headquartered additive manufacturing startup also received funding...
Researchers Rely on 3D Printed Models & Surgical Guides for Pediatric Orthopedic Surgery
Medical researchers and orthopedic surgeons in Taiwan at Kaohsiung Veterans General Hospital continue to explore better ways to heal bones and manage defects, with their findings outlined in the recently...
View our broad assortment of in house and third party products.